Cited by 615Immunotherapy and Immune Responsesvaccines and immunoinformatics approachesT-cell and B-cell Immunology

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Phagocytic processing of bacterial antigens for class I MHC presentation to T cells

Pfeifer, John D., Wick, Mary Jo, Roberts, Richard L., Findlay, Kirk, Normark, Staffan J., Harding, Clifford V.·1993·Nature

DOI 10.1038/361359a0

Open this paper in CoChat — free account

Abstract

Class I major histocompatibility complex (MHC) molecules present antigens that are produced within the presenting cell or penetrate from the vacuolar system into the cytosol for processing. Most studies of exogenous antigen processing have used soluble antigens, which are not efficiently presented by class I MHC molecules and do not elicit CD8 T-cell responses in vivo. But particulate antigen preparations with no known mechanism for cytosolic penetration can also elicit CD8 T-cell responses in vivo. We report here that phagocytosis of bacteria with no mechanism for cytosolic penetration also results in presentation of bacterial antigens by class I MHC molecules. Moreover, this mechanism is resistant to cycloheximide and Brefeldin A, which block the classical class I processing pathway. These results suggest a novel vacuolar class I processing pathway for exogenous phagocytic antigens.

Integrity signals

Registry

Crossref · 10.1038/361359a0

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
Falk, K., Rötzschke, O., Stevanovié, S., Jung, G., & Rammensee, H. (1991) · Nature · doi:10.1038/351290a0 · Cited by 2,421
Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay.
Bevan, M. J. (1976) · The Journal of Experimental Medicine · doi:10.1084/jem.143.5.1283 · Cited by 984
Fibronectin binding mediated by a novel class of surface organelles on Escherichia coll
Olsén, A., Jonsson, A., & Normark, S. J. (1989) · Nature · doi:10.1038/338652a0 · Cited by 614
Self-citation
Sequence of chicken ovalbumin mRNA
McReynolds, L. A., O’Malley, B. W., Nisbet, A. D., Fothergill, J. E., Givol, D., Fields, S., Robertson, M., & Brownlee, G. G. (1978) · Nature · doi:10.1038/273723a0 · Cited by 435
Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.
Carbone, F., & Bevan, M. J. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.2.377 · Cited by 400
Promoters largely determine the efficiency of repressor action.
Lanzer, M., & Bujard, H. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.8973 · Cited by 362
Presentation of Exogenous Antigen with Class I Major Histocompatibility Complex Molecules
Rock, K. L., Gamble, S., & Rothstein, L. (1990) · Science · doi:10.1126/science.2392683 · Cited by 335
Antigen Presentation Pathways to Class I and Class II MHC‐Restricted T Lymphocytes
Braciale, T. J., Morrison, L. A., Sweetser, M. T., Sambrook, J., Gething, M.-J. H., & Braciale, V. L. (1987) · Immunological Reviews · doi:10.1111/j.1600-065x.1987.tb00521.x · Cited by 320
Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.
Carbone, F., & Bevan, M. J. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.3.603 · Cited by 220
Cloned T Lymphocytes and Monoclonal Antibodies as Probes for Cell Surface Molecules Active in T Cell‐Mediated Cytolysis
Sarmiento, M., Dialynas, D. P., Lancki, D. W., Wall, K. A., Lorber, M. I., Loken, M. R., & Fitch, F. W. (1982) · Immunological Reviews · doi:10.1111/j.1600-065x.1982.tb01063.x · Cited by 210

Flagged first, then by citations

Show all 31 references

Sorted by citations

Items 201–300 of 611

Enhancement of Dendritic Cell Antigen Cross-Presentation by CpG DNA Involves Type I IFN and Stabilization of Class I MHC mRNA
Kuchtey, J., Chefalo, P. J., Gray, R. C., Ramachandra, L., & Harding, C. V. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2244 · Cited by 66
“Brefeldin A was added to block egress of nascent MHC-I from the Golgi apparatus (thereby defining a population of post-Golgi MHC-I for study of its stability without addition of new molecules), and cells were incubated for various chase intervals to determine decay of MHC-I expression, as assessed by staining with ant…”
BackgroundMethodInfluentialSelf-citation
Pathways of MHC I cross-presentation of exogenous antigens
Cruz, F. M., Chan, A., & Rock, K. L. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101729 · Cited by 66
Loading of MHC Class I and II Presentation Pathways by Exogenous Antigens: A Quantitative In Vivo Comparison
Storni, T., & Bachmann, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6129 · Cited by 66
Secreted Proteins from Mycobacterium tuberculosis Gain Access to the Cytosolic MHC Class-I Antigen-Processing Pathway
Lewinsohn, D. M., Grotzke, J. E., Heinzel, A. S., Zhu, L., Ovendale, P. J., Johnson, M., & Alderson, M. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.437 · Cited by 66
Association of HLA class I antigen deficiency related to a TAP2 gene mutation with familial bronchiectasis
Donato, L., de la Salle, H., Hanau, D., Tongio, M., Oswald, M., Vandevenne, A., & Geisert, J. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70024-2 · Cited by 66
Overexpression of IL-15 In Vivo Enhances Protection Against Mycobacterium bovis Bacillus Calmette-Guerin Infection Via Augmentation of NK and T Cytotoxic 1 Responses
Umemura, M., Nishimura, H., Hirose, K., Matsuguchi, T., & Yoshikai, Y. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.946 · Cited by 65
Generation of CD8+T-Cell Responses toMycobacterium bovisand Mycobacterial Antigen in Experimental Bovine Tuberculosis
Liébana, E., Girvin, R. M., Welsh, M., Neill, S. D., & Pollock, J. M. (1999) · Infection and Immunity · doi:10.1128/iai.67.3.1034-1044.1999 · Cited by 65
“(37) found that BFA-A had little effect on the processing of bacterial peptide antigens for MHC class I and that presentation of such antigens to CD8(1) cells occurred through a nonclassical pathway.”
Background
Induction of hepatitis B virus-specific cytotoxic T lymphocytes response in vivo by filamentous phage display vaccine
Wan, Y., Wu, Y., Bian, J., Wang, X., Zhou, W., Jia, Z., Tan, Y., & Zhou, L. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00561-2 · Cited by 64
Human leukocyte antigens in tuberculosis and leprosy
Meyer, C. G., May, J., & Stark, K. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(98)01240-2 · Cited by 64
The human macrophage cell line U937 as an in vitro model for selective evaluation of mycobacterial antigen‐specific cytotoxic T‐cell function
Passmore, J.-A. S., Lukey, P. T., & Ress, S. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01164.x · Cited by 64
Dendritic Cells Require the NF-κB2 Pathway for Cross-Presentation of Soluble Antigens
Lind, E. F., Ahonen, C. L., Wasiuk, A., Kosaka, Y., Becher, B., Bennett, K. A., & Noelle, R. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.354 · Cited by 60
“5a, the production of IL-2 by cultures containing DCWT was greater than those with DCAly.”
BackgroundInfluential
TAP-independent antigen presentation on MHC class I molecules: lessons from Epstein–Barr virus
Lautscham, G., Rickinson, A. B., & BLAKE, N. W. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(03)00031-5 · Cited by 63
Peptide exchange in MHC molecules
Jensen, P. E., Weber, D. A., Thayer, W. R., Westerman, L. E., & Dao, C. T. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01368.x · Cited by 63
Phagocytic processing of antigens for presentation by MHC molecules
Harding, C. V. (1995) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)88959-x · Cited by 60
Self-citation
Class I MHC presentation of exogenous antigens
Harding, C. V. (1996) · Journal of Clinical Immunology · doi:10.1007/bf01540955 · Cited by 61
“In addition, peptide regurgitation has been observed (16, 17).”
BackgroundSelf-citation
Intracellular Bacteria as Targets and Carriers for Vaccination
Mollenkopf, H., Dietrich, G., & Kaufmann, S. H. E. (2001) · Biological Chemistry · doi:10.1515/bc.2001.066 · Cited by 61
“This is especially true for antigens of salmonellae or mycobacteria (Pfeifer et al., 1993; Mazzaccaro et al., 1996).”
Background
Engineering anti-cancer nanovaccine based on antigen cross-presentation
Warrier, V. U., Makandar, A. I., Garg, M., Sethi, G., Kant, R., Pal, J. K., Yuba, E., & Gupta, R. K. (2019) · Bioscience Reports · doi:10.1042/bsr20193220 · Cited by 60
Nonclassical behavior of the thymus leukemia antigen: peptide transporter-independent expression of a nonclassical class I molecule.
Holcombe, H. R., Castaño, A. R., Cheroutre, H., Teitell, M. A., Maher, J. K., Peterson, P. A., & Kronenberg, M. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.4.1433 · Cited by 60
“Recent experiments suggest that under some circumstances post-Golgi classical class I molecules might acquire peptides (57).”
Processing of Exogenous Antigens for Presentation by Class I MHC Molecules Involves Post-Golgi Peptide Exchange Influenced by Peptide-MHC Complex Stability and Acidic pH
Chefalo, P. J., & Harding, C. V. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1274 · Cited by 59
“Vacuolar alternate MHC-I Ag processing is maintained i the presence of brefeldin A (2, 5, 22), implicating a post-Golgi pool of stabilizing peptide-MHC-I complexes that are precursors to peptide-receptive MHC-I molecules.”
InfluentialSelf-citation
Evidence for Antibody-Mediated Enhancement of Simian Immunodeficiency Virus (SIV) Gag Antigen Processing and Cross Presentation in SIV-Infected Rhesus Macaques
Villinger, F. J., Mayne, A. E., Boštík, P., Mori, K., Jensen, P. E., Ahmed, R., & Ansari, A. A. (2002) · Journal of Virology · doi:10.1128/jvi.77.1.10-24.2003 · Cited by 59
“However, several lines of investigation suggest that exogenous antigens can also be processed for presentation by MHC class I molecules utilizing several alternate mechanisms of MHC class I processing (14, 15, 17, 27, 29, 46, 50, 56, 58).”
Background
Distribution of mhc class i and of mhc class ii molecules in macrophages infected with Leishmania amazonensis
Lang, T., de Chastellier, C., Fréhel, C., Hellio, R., Métézeau, P., Leao, S. D. S., & Antoine, J.-C. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.1.69 · Cited by 58
Parameters that influence the efficiency of processing antigenic epitopes expressed in Salmonella typhimurium
Wick, M. J., Harding, C. V., Normark, S. J., & Pfeifer, J. D. (1994) · Infection and Immunity · doi:10.1128/iai.62.10.4542-4548.1994 · Cited by 59
Self-citation
Stress-Induced ClpP Serine Protease ofListeria monocytogenesIs Essential for Induction of Listeriolysin O-Dependent Protective Immunity
Gaillot, O., Bregenholt, S., Jaubert, F., Santo, J. P. D., & Berche, P. (2001) · Infection and Immunity · doi:10.1128/iai.69.8.4938-4943.2001 · Cited by 58
“Although an alternative presentation pathway may also play a role (28, 34), Listeria antigens are mainly processed by the cytosolic pathway.”
Background
Thermolabile H-2Kb Molecules Expressed by Transporter Associated with Antigen Processing-Deficient RMA-S Cells Are Occupied by Low-Affinity Peptides
Silva, A. D. D., Boesteanu, A. C., Song, R., Nagy, N., Harhaj, E. W., Harding, C. V., & Joyce, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4413 · Cited by 58
Self-citation
Pathogenesis of reactive arthritis
Sieper, J. (2001) · Current Rheumatology Reports · doi:10.1007/s11926-996-0012-8 · Cited by 58
Induction of interferon-γ production in Th1 CD4+ T cells: evidence for two distinct pathways for promoter activation
Yang, J., Murphy, T. L., Ouyang, W., & MURPHY, K. M. M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199902)29:02 · Cited by 195
Salmonella typhimurium delta aroA delta aroD mutants expressing a foreign recombinant protein induce specific major histocompatibility complex class I-restricted cytotoxic T lymphocytes in mice
Turner, S. T., Carbone, F., & Strugnell, R. A. (1993) · Infection and Immunity · doi:10.1128/iai.61.12.5374-5380.1993 · Cited by 58
“(28) by showing that ovalbuminexpressing bacteria can also access the MHC class I presentation pathway for effective in vivo CTL priming.”
BackgroundInfluential
Leishmania major infection in mice primes for specific major histocompatibility complex class I‐restricted CD8+ cytotoxic T cell responses
Conceição‐Silva, F., Perlaza, B. L., Louis, J. A., & Romero, P. J. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241135 · Cited by 57
Expression of multiple forms of IL-1 receptor antagonist (IL-1ra) by human retinal pigment epithelial cells: identification of a new IL-1ra exon
Holtkamp, G. M., de Vos, A. F., Kijlstra, A., & Peek, R. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199901)29:01 · Cited by 31
Self-citation
The Biochemistry and Cell Biology of Antigen Presentation by MHC Class I and Class II Molecules
Germain, R. N. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44444.x · Cited by 56
Cutting Edge: Efficient MHC Class I Cross-Presentation during Early Vaccinia Infection Requires the Transfer of Proteasomal Intermediates between Antigen Donor and Presenting Cells
Serna, A. N., Ramirez, M. C., Soukhanova, A., & Sigal, L. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5668 · Cited by 56
“In the vacuolar route, the proteins are degraded within endocytic compartments and the peptides bind to recycling class I molecules without accessing the cytosol (9).”
Background
Antigen Release Kinetics in the Phagosome Are Critical to Cross-Presentation Efficiency
Howland, S. W., & Wittrup, K. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1576 · Cited by 55
“Early reports of cross-presentation presented conflicting results as to whether this process required TAP and was sensitive to proteasome inhibitors (10), or was TAP-independent and sensitive to protease inhibitors (11, 12).”
Result
Phagocytic antigen processing and effects of microbial products on antigen processing and T‐cell responses
Ramachandra, L., Chu, R. S., Askew, D. S., Noss, E. H., Canaday, D. H., Potter, N., Johnsen, A. K., Krieg, A. Μ., Nedrud, J. G., Boom, W. H., et al. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01295.x · Cited by 55
Self-citation
Characterization of T cells that confer a high degree of protective immunity against tuberculosis in mice after vaccination with tumor cells expressing mycobacterial hsp65
Silva, C. A., Silva, M. F., Pietro, R. C. L. R., & Lowrie, D. B. (1996) · Infection and Immunity · doi:10.1128/iai.64.7.2400-2407.1996 · Cited by 55
“There is evidence in both directions (2, 22, 32), and further study is needed.”
Background
Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monomeric hepatitis B virus surface (S) antigen
Schirmbeck, R., Melber, K., Mertens, T., & Reimann, J. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240512 · Cited by 55
Induction of HIV‐1 envelope (gp120)‐specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell‐derived gp120 is enhanced by enzymatic removal of N‐linked glycans
Doe, B., Steimer, K. S., & Walker, C. M. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241017 · Cited by 54
Efficient Delivery of Antennapedia Homeodomain Fused to CTL Epitope with Liposomes into Dendritic Cells Results in the Activation of CD8+ T Cells
Chikh, G., Kong, S., Bally, M. B., Meunier, J.-C., & Schutze-Redelmeier, M.-P. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6462 · Cited by 53
“The processing pathway followed by liposome-associated AntpHD-Cw3 differs from the typical processing of endocytosed proteins, where the processed peptides bind recycling class I molecules in vacuolar compartment (52, 53).”
Background
Tapasin−/− and TAP1−/− Macrophages Are Deficient in Vacuolar Alternate Class I MHC (MHC-I) Processing due to Decreased MHC-I Stability at Phagolysosomal pH
Chefalo, P. J., Grandea, A. G., Kaer, L. V., & Harding, C. V. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.5825 · Cited by 53
“Crl-OVA constitutively expresses the Crl-OVA fusion protein, containing the OVA sequence residues 257–277 fused to the bacterial cytoplasmic regulatory protein Crl (2).”
BackgroundMethodResultInfluentialSelf-citation
Delivery of class I and class II MHC-restricted T-cell epitopes of listeriolysin of Listeria monocytogenes by attenuated Salmonella
Verma, N. K., Ziegler, H., Wilson, M. R., Khan, M., Safley, S. A., Stocker, B. A. D., & Schoolnik, G. K. (1995) · Vaccine · doi:10.1016/0264-410x(95)93127-u · Cited by 53
Processing of bacterial antigens for peptide presentation on MHC class I molecules
Wick, M. J., & Ljunggren, H. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01363.x · Cited by 53
Self-citation
Different hepatitis C virus nonstructural protein 3 (Ns3)-DNA-expressing vaccines induce in HLA-A2.1 transgenic mice stable cytotoxic T lymphocytes that target one major epitope
Brinster, C., Muguet, S., Lone, Y. C., Boucreux, D., Renard, N., Fournillier, A., Lemonnier, F. A., & Inchauspé, G. (2001) · Hepatology · doi:10.1053/jhep.2001.29304 · Cited by 53
The ongoing saga of the mechanism(s) of MHC class I-restricted cross-presentation
Grotzke, J. E., Sengupta, D., Qiao, L., & Cresswell, P. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.03.015 · Cited by 52
Cutting Edge: Limited Specialization of Dendritic Cell Subsets for MHC Class II-Associated Presentation of Viral Particles
Keller, S. A., Bauer, M., Manolova, V., Muntwiler, S., Saudan, P., & Bachmann, M. F. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901540 · Cited by 52
Immunological properties and vaccine efficacy of murine dendritic cells simultaneously expressing melanoma-associated antigen and interleukin-12
Okada, N., Iiyama, S., Okada, Y., Mizuguchi, H., Hayakawa, T., Nakagawa, S., Mayumi, T., Fujita, T., & Yamamoto, A. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700772 · Cited by 51
Mycobacterium tuberculosis Heat Shock Fusion Protein Enhances Class I MHC Cross-Processing and -Presentation by B Lymphocytes
Tobian, A. A. R., Harding, C. V., & Canaday, D. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5209 · Cited by 52
“3 T hybridoma cells (10(5) cells/well), which are specific for OVA257–264:K b complexes (37).”
BackgroundSelf-citation
DCs at the center of help: Origins and evolution of the three-cell-type hypothesis
Wu, R., & MURPHY, K. M. M. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20211519 · Cited by 52
Interaction of bacteria with antigen presenting cells: influences on antigen presentation and antibacterial immunity
Harding, C. V., Ramachandra, L., & Wick, M. J. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00008-0 · Cited by 51
Self-citation
Major histocompatibility complex class I‐binding peptides are recycled to the cell surface after internalization
Abdel‐Motal, U. M., Zhou, X., Joki, A., Siddiqi, A. R., Srinivasa, B. R., Stenvall, K., Dahmén, J., & Jondal, M. (1993) · European Journal of Immunology · doi:10.1002/eji.1830231227 · Cited by 51
Efficient scavenger receptor‐mediated uptake and cross‐presentation of negatively charged soluble antigens by dendritic cells
Shakushiro, K., Yamasaki, Y., Nishikawa, M., & Takakura, Y. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01871.x · Cited by 50
Proliferation of distinct human T cell subsets in response to live, killed or soluble extracts of Mycobacterium tuberculosis and Myco. avium
Esin, S., Batoni, G., Källenius, G., Gaines, H., Campa, M., Svenson, S. B., Andersson, R., & Wigzell, H. (1996) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1996.d01-691.x · Cited by 50
‘Empty’ Ld molecules capture peptides from endocytosed hepatitis B surface antigen particles for major histocompatibility complex class I‐restricted presentation
Schirmbeck, R., & Reimann, J. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261204 · Cited by 50
Experimental Approaches to Mechanisms of Protection and Pathogenesis in M. tuberculosis Infection
Bloom, B. R., Flynn, J. L., McDonough, K. A., Kress, Y., & Chan, J. (1994) · Immunobiology · doi:10.1016/s0171-2985(11)80459-6 · Cited by 48
Sialoadhesin-Positive Host Macrophages Play an Essential Role in Graft-Versus-Leukemia Reactivity in Mice
Müerköster, S. S., Rocha, M., Crocker, P. R., Schirrmacher, V., & Umansky, V. (1999) · Blood · doi:10.1182/blood.v93.12.4375 · Cited by 49
Cross-presentation: inducing CD8 T cell immunity and tolerance
Kurts, C. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000108 · Cited by 49
“As noted above, naive T cells do not efficiently enter nonlymphoid areas of the body but rather recirculate between the secondary lymphoid organs [1, 2, 3].”
MHC Class I Antigen Processing Pathways
Maffei, A., Papadopoulos, K. P., & Harris, P. E. (1997) · Human Immunology · doi:10.1016/s0198-8859(97)00084-0 · Cited by 49
Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway
Melero, I., Bach, N., Hellström, K. E., Aruffo, A. A., Mittler, R. S., & Chen, L. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199803)28:03 · Cited by 215
Transporters Associated with Antigen Processing (TAP)-independent Presentation of Soluble Insulin to α/β T Cells by the Class Ib Gene Product, Qa-1b
Tompkins, S. M., Leavey, J. K., Dao, C. T., Soloski, M. J., & Jensen, P. E. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.961 · Cited by 49
“Presentation of exogenous proteins by class I molecules in macrophages is markedly enhanced under conditions favoring uptake of antigen by phagocytosis (54, 56, 57, 64) or macropinocytosis (48).”
Background
Escape from the Phagosome: The Explanation for MHC-I Processing of Mycobacterial Antigens?
Harriff, M. J., Purdy, G. E., & Lewinsohn, D. M. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00040 · Cited by 48
Bacterial Proteins Can Be Processed by Macrophages in a Transporter Associated with Antigen Processing-Independent, Cysteine Protease-Dependent Manner for Presentation by MHC Class I Molecules
Campbell, D., Serwold, T. F., & Shastri, N. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.168 · Cited by 48
“Alternatively, the antigenic protein could be processed and loaded on to MHC-I in an alternate MHC-I pathway that did not require access to the cytosol (25, 36).”
BackgroundResult
Exogenous antigen targeted to FcγRI on myeloid cells is presented in association with MHC class I
Wallace, P. K., Tsang, K. Y., Goldstein, J., Correale, P., Jarry, T. M., Schlom, J., Guyre, P. M., Ernstoff, M. S., & Fanger, M. W. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00351-3 · Cited by 48
Antigen Processing and Remodeling of the Endosomal Pathway: Requirements for Antigen Cross-Presentation
Compeer, E., Flinsenberg, T., van der Grein, S. G., & Boes, M. (2012) · Front. Immun. · doi:10.3389/fimmu.2012.00037 · Cited by 47
The delivery of an antigen from the endocytic compartment into the cytosol for cross‐presentation is restricted to early immature dendritic cells
Hotta, C., Fujimaki, H., Yoshinari, M., Nakazawa, M., & Minami, M. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02270.x · Cited by 47
Bacterium-host cell interactions at the cellular level: fluorescent labeling of bacteria and analysis of short-term bacterium-phagocyte interaction by flow cytometry
Raybourne, R. B., & Bunning, V. K. (1994) · Infection and Immunity · doi:10.1128/iai.62.2.665-672.1994 · Cited by 47
“Knowledge of bacterial viability within antigen-processing cells is potentially important for antigen presentation, since two distinct mechanisms of presentation by class I major histocompatibility complex molecules have been described (19).”
Background
Amorphous silica nanoparticles enhance cross-presentation in murine dendritic cells
Hirai, T., Yoshioka, Y., Takahashi, H., Ichihashi, K.-I., Yoshida, T., Tochigi, S., Nagano, K., Abe, Y., Kamada, H., Tsunoda, S., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.09.095 · Cited by 46
“3 cells, a T–T hybridoma against the OVA257–264/MHC class I molecule (H-2 Kb) complex [21], were kindly provided by Dr.”
Method
Leishmania major‐specific CD8+ T cells are inducers and targets of nitric oxide produced by parasitized macrophages
Stefani, M. M. A., Müller, I., & Louis, J. A. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240338 · Cited by 46
Splenic B Cells Act as Antigen Presenting Cells for the Induction of Anterior Chamber-Associated Immune Deviation
Skelsey, M. E. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0768 · Cited by 45
Trafficking of spontaneously endocytosed MHC proteins
Chiu, I. M., Davis, D. M., & Strominger, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13944 · Cited by 45
Just-in-time vaccines: Biomineralized calcium phosphate core-immunogen shell nanoparticles induce long-lasting CD8+ T cell responses in mice
Zhou, W., Moguche, A. O., Chiu, D., Murali‐Krishna, K., & Baneyx, F. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.11.007 · Cited by 44
“In addition, the presence of multiple immunogens on each nanoparticle is likely to improve loading on class I MHC molecules as cross-presentation of antigens attached or adsorbed to particles in the 20 nm to 3 μm size range is more efficient than with soluble proteins.(32,33) The role of the inorganic core is less cle…”
Cross-presentation of IgG-containing immune complexes
Baker, K., Räth, T., Lencer, W. I., Fiebiger, E., & Blumberg, R. S. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1100-8 · Cited by 48
Cancer Acidity and Hypertonicity Contribute to Dysfunction of Tumor-Associated Dendritic Cells: Potential Impact on Antigen Cross-Presentation Machinery
Burgdorf, S., Porubský, Š., Marx, A., & Popović, Z. V. (2020) · Cancers · doi:10.3390/cancers12092403 · Cited by 48
“Although both cross-presentation pathways have been well-documented in the past [31,32], most of the published data point to the endosome-to-cytosol pathway as a dominant mechanism of cross-presentation.”
Background
Two Human Immunodeficiency Virus Vaccinal Lipopeptides Follow Different Cross-Presentation Pathways in Human Dendritic Cells
Andrieu, M., Desoutter, J.-F., Loing, E., Gaston, J., Hanau, D., Guillet, J., & Hosmalin, A. (2002) · Journal of Virology · doi:10.1128/jvi.77.2.1564-1570.2003 · Cited by 44
“The processing pathway of the antigen depends not only on the presence of cleavage and binding sites for the proteasomes or for other antigen-processing enzymes, but also on the availability to these enzymes (endosome/lysosomes versus cytosol, endoplasmic reticulum, or nucleus) (4, 8, 26, 34, 37, 38).”
Background
Antigen cross-presentation: extending recent laboratory findings to therapeutic intervention
Flinsenberg, T. W. H., Compeer, E. B., Boelens, J. J., & Boes, M. L. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04411.x · Cited by 43
Dendritic Cells That Endocytosed Antigen-Containing IgG-Liposomes Elicit Effective Antitumor Immunity
Kawamura, K., Kadowaki, N., Suzuki, R., Udagawa, S., Kasaoka, S., Utoguchi, N., Kitawaki, T., Sugimoto, N., Okada, N., Maruyama, K., et al. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000190169.61416.f5 · Cited by 43
Survival ofSalmonella entericaSerovar Typhimurium within Late Endosomal-Lysosomal Compartments of B Lymphocytes Is Associated with the Inability To Use the Vacuolar Alternative Major Histocompatibility Complex Class I Antigen-Processing Pathway
Rosales-Reyes, R., Alpuche-Aranda, C. M., Ramírez-Aguilar, M. D. L. L., Castro-Eguiluz, D., & Ortiz-Navarrete, V. F. (2005) · Infection and Immunity · doi:10.1128/iai.73.7.3937-3944.2005 · Cited by 43
“Ags in a noncharacterized endocytic compartment followed by secretion and loading of antigenic peptides into MHC-I molecules on the macrophages’ cell surface and bystander cells (30, 43).”
Background
Phagocytosis and antigen presentation
Watts, C. K. W., & Amigorena, S. (2001) · Seminars in Immunology · doi:10.1006/smim.2001.0334 · Cited by 43
Antigen-presenting cells and anti- immunity
Yrlid, U., Svensson, M., Kirby, A. C., & Wick, M. J. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01484-8 · Cited by 43
Self-citation
Antigen processing mutant T2 cells present viral antigen restricted through H‐2K
Zhou, X., Glas, R., Liu, T., Ljunggren, H., & Jondal, M. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230811 · Cited by 43
Alternative antigen processing pathways in anti-infective immunity
Reimann, J., & Kaufmann, S. H. E. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80096-9 · Cited by 43
The role of endosomes in innate and adaptive immunity
Gleeson, P. A. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.03.002 · Cited by 47
Autodisplay: Development of an Efficacious System for Surface Display of Antigenic Determinants inSalmonellaVaccine Strains
Kramer, U., Rizos, K., Apfel, H., Autenrieth, I. B., & Lattemann, C. T. (2003) · Infection and Immunity · doi:10.1128/iai.71.4.1944-1952.2003 · Cited by 42
“Since antigen processing for MHC class I pathway by antigen-presenting cells infected with Salmonella strains has been demonstrated (37), it is tempting to speculate that an efficient cytotoxic immune response might also be induced by surface-displayed antigens.”
Background
The efficiency of antigen delivery from macrophage phagosomes into cytoplasm for MHC class I-restricted antigen presentation
Oh, Y., Harding, C. V., & Swanson, J. A. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00221-1 · Cited by 42
Self-citation
Antigen processing and intracellular traffic of antigens and MHC molecules
Harding, C. V., & Geuze, H. J. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90128-d · Cited by 42
Self-citation
Presentation of Exogenous Protein Antigens on Major Histocompatability Complex Class I Molecules by Dendritic Cells: Pathway of Presentation and Regulation by Cytokines
Brossart, P., & Bevan, M. J. (1997) · Blood · doi:10.1182/blood.v90.4.1594.1594_1594_1599 · Cited by 42
Secreted Immunodominant Mycobacterium tuberculosis Antigens Are Processed by the Cytosolic Pathway
Grotzke, J. E., Siler, A. C., Lewinsohn, D. A., & Lewinsohn, D. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000801 · Cited by 42
“vacuolar presentation pathway is insensitive to cycloheximide treatment (36).”
Background
No life without death—apoptosis as prerequisite for T cell activation
Winau, F., Hegasy, G. A., Kaufmann, S. H. E., & Schaible, U. E. (2005) · APOPTOSIS · doi:10.1007/s10495-005-2940-6 · Cited by 41
MHC Class I-Restricted Presentation of Maleylated Protein Binding to Scavenger Receptors
Bansal, P., Mukherjee, P., Basu, S. K., George, A., Bal, V., & Rath, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4430 · Cited by 41
“While fluid-phase proteins are processed and presented by APCs of the monocytic lineage for MHC class I-restricted presentation (27), the efficiency of this presentation has been shown to improve markedly if the Ag is taken up by phagocytosis in either Salmonellae (44), Escherichia coli(45), acid-resistant liposomes (…”
Background
Cytotoxic T lymphocyte response in mice induced by a recombinant BCG vaccination which produces an extracellular α antigen that fused with the human immunodeficiency virus type 1 envelope immunodominant domain in the V3 loop
Kameoka, M., Nishino, Y., Matsuo, K., Ohara, N., Kimura, T., Yamazaki, A., Yamada, T., & Ikuta, K. (1994) · Vaccine · doi:10.1016/0264-410x(94)90054-x · Cited by 41
Murine cytotoxic T lymphocytes induced following Chlamydia trachomatis intraperitoneal or genital tract infection respond to cells infected with multiple serovars
Starnbach, M. N., Bevan, M. J., & Lampe, M. F. (1995) · Infection and Immunity · doi:10.1128/iai.63.9.3527-3530.1995 · Cited by 40
“Alternative pathways of antigen processing and presentation to CTL are an area of current investigation in several laboratories (3, 7, 8, 13, 14).”
Background
Gene transduction efficiency and maturation status in mouse bone marrow-derived dendritic cells infected with conventional or RGD fiber-mutant adenovirus vectors
Okada, N., Masunaga, Y., Okada, Y., Iiyama, S., Mori, N., Tsuda, T., Matsubara, A., Mizuguchi, H., Hayakawa, T., Fujita, T., et al. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700586 · Cited by 40
Role of cytotoxic cells in the protective immunity against and immunopathology of intracellular infections
Ottenhoff, T. H. M., & Mutis, T. (1995) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1995.tb01716.x · Cited by 40
Class II Major Histocompatibility Complex-Deficient Mice Initially Control an Infection with Leishmania major but Succumb to the Disease
Chakkalath, H. R., Theodos, C. M., Markowitz, J. S., Grusby, M. J., Glimcher, L. H., & Titus, R. G. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.5.1302 · Cited by 40
Introduction of protein or DNA delivered via recombinant into the major histocompatibility complex class I presentation pathway of macrophages
Catic, A., Dietrich, G., Gentschev, I., Goebel, W., Kaufmann, S. H. E., & Hess, J. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)80001-x · Cited by 40
Internalization of Iscom-Borne Antigens and Presentation under MHC Class I or Class II Restriction
Villacres, M. C., Behboudi, S., Nikkila, T., Lövgren-Bengtsson, K., & Morein, B. (1998) · Cellular Immunology · doi:10.1006/cimm.1998.1278 · Cited by 40
The Endoplasmic Reticulum Chaperone GRP170: From Immunobiology to Cancer Therapeutics
Wang, H., Pezeshki, A. M., Yu, X., Guo, C., Subjeck, J. R., & Wang, X. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2014.00377 · Cited by 41
Activation of the Janus Kinase 3-STAT5a Pathway After CD40 Triggering of Human Monocytes But Not of Resting B Cells
Revy, P., Hivroz, C., Andreu, G., Graber, P., Martinache, C., Fischer, A., & Durandy, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.787 · Cited by 39
Presentation of Listeria monocytogenes antigens by major histocompatibility complex class I molecules to CD8 cytotoxic T lymphocytes independent of listeriolysin secretion and virulence
Szalay, G., Hess, J., & Kaufmann, S. H. E. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240703 · Cited by 39
Phase I Study to the Immunotherapy of Metastatic Malignant Melanoma by a Cancer Vaccine Consisting of Autologous Cancer Cells Transfected with the Human IL-2 Gene. University of Vienna, Austria
Stingl, G., Bröcker, E. ‐., Mertelsmann, R. H., Wolff, K., Schreiber, S. C., Kämpgen, E., Schneeberger, A., Dummer, W., Brennscheid, U., Veelken, H., et al. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.4-551 · Cited by 39
“…presentation) The recent demonstration of successful presentation of exogenous antigens in the context of M HC class I molecules (Rock et al., 1990; Pfeifer et al., 1993) opens the possibility that even the generation of M HC class I-restricted, CDS'*", M-3 specific cytotoxic cells did not occur…”
Stress protein (hsp73)‐mediated, TAP‐independent processing of endogenous, truncated SV 40 large T antigen for Db‐restricted peptide presentation
Schirmbeck, R., Böhm, W., & Reimann, J. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270828 · Cited by 39
Availability of endogenous peptides limits expression of an M3a-Ld major histocompatibility complex class I chimera.
Vyas, J. M., Rich, R. R., Howell, D. D., Shawar, S. M., & Rodgers, J. R. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.1.155 · Cited by 39
“M HC class I molecules monitor the interior of cells for the presence of peptides derived from pathogens such as viruses and intracellular bacteria (1, 2).”
Induction of Vigorous Helper and Cytotoxic T Cell as well as B Cell Responses by Dendritic Cells Expressing a Modified Antigen Targeting Receptor-Mediated Internalization Pathway
You, Z., Huang, X. F., Hester, J. H., Rollins, L. A., Rooney, C. M., & Chen, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4581 · Cited by 38

Authors: Pfeifer, J. D., Wick, M. J., Roberts, R. L., Findlay, K., Normark, S. J., & Harding, C. V.
Affiliations: Washington University in St. Louis (US)
ORCID: Pfeifer, John D.
Wick, Mary Jo
Normark, Staffan J.
Harding, Clifford V.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 1993-01
Volume: 361
Issue: 6410
Pages: 359-362
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/361359a0
OpenAlex: W2042470561
Cited by: 615
References: 31
Citations by year: 2026: 2 · 2025: 3 · 2024: 2 · 2023: 7 · 2022: 3 · 2021: 6 · 2020: 8 · 2019: 6 · 2018: 8 · 2017: 9 · 2015: 4 · 2014: 8 · 2013: 10 · 2012: 10
FWCI: 22.81
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords: MHC class I, antigen processing, phagocytosis, bacterial antigens, CD8+ T cells, exogenous antigen presentation, cycloheximide resistance, particulate antigen
MeSH terms: Amino Acid Sequence, Animals, Epitopes, Antigens, Bacterial, Bacterial Proteins, Escherichia coli, Macrophages, Mice, Inbred CBA, Mice, Inbred C57BL, Microscopy, Electron, Molecular Sequence Data, Ovalbumin, Phagocytosis, Recombinant Fusion Proteins, Salmonella typhimurium, T-Lymphocytes, Vacuoles, Histocompatibility Antigens Class I, T-Lymphocyte Subsets, CD8 Antigens, Escherichia coli Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Phagocytic processing of bacterial antigens for class I MHC presentation to T cells

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks